What was up with the Ramsay Health Care (ASX:RHC) share price today?

Seemingly bad news didn't adversely affect the private hospital operator's shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Ramsay Health Care Limited (ASX: RHC) finished in the green today despite the company facing delays to an ongoing acquisition proposal. The Ramsay share price closed up 1.34%, with shares in the private hospital operator trading for $64.39 apiece.

Let's take a look at the latest news of the ongoing acquisition.

Doctor reading a file

Image source: Getty Images

The latest on Ramsay's acquisition

Today, Ramsay announced the shareholder vote for its proposed acquisition of UK-based private hospital operator Spire Healthcare has been pushed back a week. It will now take place on 19 July.

The Ramsay share price hasn't noticeably reacted to today's news.

The delay follows news Ramsay increased its cash offer for Squire yesterday. It also comes amid rumours members of Spire Healthcare's board are against the acquisition.

Yesterday, Ramsay announced it has upped its acquisition offer by 10 pence to 250 pence per Spire Healthcare share. However, a shareholder's vote needs to take place before the acquisition can go before a court hearing.

The court hearing is the final step Ramsay needs to pass before acquiring Spire Healthcare. It will now take place on 22 July.

Other news on Ramsay's acquisition was published by The Australian today.

The publication claimed 2 of Spire Healthcare's shareholders, Toscafund and Fidelity, who respectively hold 5.5% and 8.8% of Spire Healthcare's outstanding shares, vehemently oppose the acquisition.

Toscafund's CEO reportedly believes Ramsay's offer undervalues Spire Healthcare.

Additionally, both companies supposedly opposing the acquisition have recently sold stakes in the UK's Circle Health for a combined $3.5 billion. According to The Australian, they plan to spend some of the cash to battle Ramsay's bid.

Ramsay needs the approval of at least 75% of Spire Healthcare's shareholders to go ahead with the acquisition. It currently holds 30% of Spire Healthcare's shares.

Ramsay Health Care share price snapshot

With today's gains included, the Ramsay share price has grown 2.7% in 2021. It has also gained 1.9% since this time last year.

The company has a market capitalisation of around $14.4 billion, with approximately 228 million shares outstanding.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

Why ResMed shares are tumbling 6% today despite strong results

Here's what spooked investors.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Imricor Medical Systems shares: Philips declares compatibility for iMR products

Big news is catching the eye of investors on Friday.

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Earnings Results

ResMed posts strong Q4 earnings, lifts dividend

The sleep disorder treatment company had another record quarter.

Read more »

a doctor wearing a white coat with a stethoscope around her neck stares out a window with her hand to the side of her face as though in deep thought.
Healthcare Shares

Clarity Pharmaceuticals reports clinical trial milestones

Clarity Pharmaceuticals reported continued clinical progress for its prostate cancer imaging and therapy programs.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Are Neuren Pharmaceuticals shares a buy, hold or sell after rocketing 16%?

This healthcare stock keeps rising.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Clarity Pharmaceuticals reports new SECuRE trial responses at higher dose

Clarity Pharmaceuticals reports further progress in its SECuRE prostate cancer trial, showing strong PSA responses and new complete responses at…

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Neuren Pharmaceuticals share price rockets: record Q2 DAYBUE sales and royalty upgrade

Second quarter net sales of DAYBUE increased 30%.

Read more »